论文部分内容阅读
在过去的十年中 ,抗心律失常药明显地有从Ⅰ类转向Ⅲ类的趋势 ,特别是ＣＡＳＴ(ｔｈｅｃａｒｄｉａｃａｒｒｈｙｔｈｍｉａｓｕｐｐｒｅｓｓｉｏｎｔｒｉａｌ)研究表明 ,Ⅰ类抗心律失常药能增加心肌梗死后高危病人的死亡率以来 ,基础和临床研究把注意力集中到Ⅲ类抗心律失常药
Over the past decade, there has been a clear trend toward antiarrhythmic drugs turning from type I to type III. In particular, the CAST study showed that type I antiarrhythmic drugs increase the mortality of high-risk patients after myocardial infarction, Basic and clinical studies have focused on Class III antiarrhythmic drugs